Dr. Singer is the company’s Chief Scientific Officer. A former medical director at Novartis and chief scientist at HealthHonors, he has supervised development of numerous new therapies. His research spans over 20 years in the basic and clinical sciences, with award of competitive grants and publications in journals such as Nature and PNAS. Dr. Singer is a board-certified ophthalmologist and a registered U.S. patent agent. He has served as a Surgeon in the Veterans Health Administration and currently serves on the clinical faculty at Harvard Medical School. Dr. Singer completed residency at Harvard and holds a BS, MD, and PhD from Yale University.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Anodyne Nanotech | Board Of Directors | Jan 1, 2020 | — | Detail |